产品说明
应用
BTZO-1 may be used in ARE-mediated gene expression studies.
包装
5, 25 mg in glass bottle
生化/生理作用
BTZO-1 is a suppressor of cardiomyocyte apoptosis presumably by activation of antioxidant response element (ARE)-mediated gene expression. BTZO-1 binds to the macrophage migration inhibitory factor (MIF) that is required to activate the glutathione S-transferase Ya subunit (GST Ya) gene ARE.
特点和优势
This compound was developed by Takeda. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
基本信息
| 经验(实验)分子式 | C13H8N2OS |
| 分子量 | 240.28 |
| MDL编号 | MFCD19690951 |
| PubChem化学物质编号 | 329825172 |
| NACRES | NA.77 |
产品性质
| 质量水平 | 100 |
| 测定 | ≥98% (HPLC) |
| 形式 | powder |
| 颜色 | white to tan |
| 溶解性 | DMSO: ≥7 mg/mL |
| 创始人 | Takeda |
| 储存温度 | 2-8℃ |
| SMILES string | O=C1N=C(Sc2ccccc12)c3ccccn3 |
| InChI | 1S/C13H8N2OS/c16-12-9-5-1-2-7-11(9)17-13(15-12)10-6-3-4-8-14-10/h1-8H |
| InChI key | GBAKVEWPYUIGHN-UHFFFAOYSA-N |
安全信息
| 储存分类代码 | 13 - Non Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
Sigma-Aldrich
m.cnreagent.com
